Biomarkers used to evaluate smoking in COPD patients

A. Trofor (Iasi (Iasi), Romania), I. Buculei (Iasi (Iasi), Romania), M. Dobrin (Iasi (Iasi), Romania), R. Cernat (Iasi (Iasi), Romania), L. Trofor (Cagnes sur Mer, France), O. Melinte (Iasi (Iasi), Romania), C. Vicol (Iasi (Iasi), Romania), E. Stavarache (Iasi (Iasi), Romania)

Source: International Congress 2022 – Epidemiology: products and diseases

Session: Epidemiology: products and diseases
Session type: Thematic Poster
Number: 3928

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Trofor (Iasi (Iasi), Romania), I. Buculei (Iasi (Iasi), Romania), M. Dobrin (Iasi (Iasi), Romania), R. Cernat (Iasi (Iasi), Romania), L. Trofor (Cagnes sur Mer, France), O. Melinte (Iasi (Iasi), Romania), C. Vicol (Iasi (Iasi), Romania), E. Stavarache (Iasi (Iasi), Romania). Biomarkers used to evaluate smoking in COPD patients. 3928

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.